S209: primary results from the phase 3 shine study of ibrutinib in combination with bendamustine-rituximab (br) and r maintenance as a first-line treatment for older patients with mantle-cell lymphomaM. L. Wang, W. Jurczak, M. Jerkeman, J. Trotman, P. L. Zinani, D. Belada,C. Boccomini,I. W. Flinn,P. Giri, A. Goy, P. A. Hamlin, O. Hermine,J.-Á. Hernández-Rivas, X. Hong,S. J. Kim, D. Lewis, Y. Mishima, M. Özcan, G. F. Perini,C. Pocock, Y. Song, S. E. Spurgeon, J. M. Storring, J. Walewski,J. Zhu, R. Qin, T. Henninger, S. Deshpande, A. Howes,S. Le Gouill, M. DreylingHemaSphere（2022）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
